660,000 people die from malaria every year, which company recently developed the vaccine, named RTS, S, and believed to halve the cases of malaria.
Share
Lost your password? Please enter your email address. You will receive a link and will create a new password via email.
GlaxoSmithKline
eAnswers Team
The British drug company “GlaxoSmithKline” has made a vaccine which can be used to reduce the cases of malaria by 50%. It is expected that the vaccine will be available in the market by 2015.